Hologic (HOLX) Reports In-Line Q2 EPS; Withdraws Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Hologic Announces Financial Results for Second Quarter of Fiscal 2020
April 29, 2020 4:01 PM EDTRevenue of $756.1 Million Declines 7.6% due to Cynosure Divestiture, 7.1% in Constant Currency
Organic Revenue Increases 0.5%, 1.1% in Constant Currency
Company Posts GAAP Diluted EPS of $0.36, Non-GAAP Diluted EPS of $0.57
Company to Introduce Second High-Throughput Coronavirus Test for Panther® Platform
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX) announced today the Companys financial results for the fiscal second quarter ended March 28, 2020.
Our second quarter revenue results reflect the strong underlying momentum that has been building at Hologic over the last... More
